At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
CMS Moves to All Electronic Filing for Claims Documentation
The Centers for Medicare and Medicaid Services (CMS) announced on March 20, 2026, the Administrative Simplification, Adoption of Standards for Health Care Claims Attachments Transactions…
New ABN Available from CMS
As of March 13, 2026, CMS has released an updated Advanced Beneficiary Notice (ABN). The revised form carries a date of March 31, 2029, and…
Join Your Community at AAA 2026
Whether you come for the evidence-based education, a plethora of practice management sessions applicable to all practice settings, the opportunity to explore the latest technology…


